Paliperidone palmitate study design [Design Issues]

posted by M.tareq  – 2017-06-29 14:47 (2785 d 16:45 ago) – Posting: # 17509
Views: 6,862

Thanks alot Detlew for your reply

Another question does the side of the body mean right or left side of the body will contribute to variability between test to reference? or the model should include another factor for grouping based on right / left side of the body if the subjects were divided into left side injection and right side ? according to spc : alternate injection sites between sides of the body ?

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
36 visitors (0 registered, 36 guests [including 2 identified bots]).
Forum time: 06:33 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5